Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Robotic versus manual cochlear implant electrode insertion to reduce inner-ear trauma.

Official title: Iowa Cochlear Implant Clinical Research Center Study on Robotic-Assisted Versus Manual Electrode Array Insertion

Run by University of Iowa · NCT06951594 · Data updated 2026-11-12

This test tries a robotic insertion tool versus the usual manual technique to see if it reduces inner-ear damage and preserves residual hearing in people getting cochlear implants.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity of Iowa
Academic / other
Locations1 site (Iowa City, Iowa)
StatusRecruiting
StartedJune 30, 2025
Main results expectedMarch 31, 2028
Study endsAugust 31, 2028
Registry record updatedOctober 16, 2026
Trial IDNCT06951594 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults eligible for cochlear implantation with normal cochlear anatomy, no ossification, and willingness to comply with study procedures are ideal candidates.

Probably not a fit

Patients with cochlear ossification, anatomical abnormalities that prevent full insertion, or medical/psychological contraindications are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized interventional study adults receiving cochlear implants are assigned to electrode insertion either with the iotaSOFT™ robotic-assisted system or with conventional manual technique. The robotic system controls insertion speed (0.1–1.0 mm/sec) and can integrate intraoperative ECochG monitoring to permit micrometer-scale stopping when inner-ear responses change, aiming to reduce insertion force and pressure variability. Outcomes include postoperative CT measures of cochlear trauma, cochlear and auditory nerve function with ECochG and eCAP, and clinical outcomes such as residual acoustic hearing and speech perception scores. The trial is conducted at the University of Iowa and enrolls candidates with patent, normally formed cochleae who meet standard cochlear implant eligibility and have no cochlear ossification or other contraindications.

Why it matters

Potential benefit: If successful, robotic-assisted insertion could lower intracochlear trauma, help preserve residual hearing, and improve speech outcomes after cochlear implantation.

How similar studies have gone: Cadaver and bench studies show the iotaSOFT™ system reduces insertion forces and intracochlear pressure compared with manual insertion, but clinical benefits in live patients remain unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Candidate for a cochlear implant according to CMS guidelines
* Willingness to comply with all study requirements
* Patent cochlea and normal cochlear anatomy, as confirmed by preoperative imaging
* English speaking

Exclusion Criteria:

* Medical or psychological conditions that contraindicate undergoing surgery
* Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array.
* Unrealistic expectations on the part of the candidate and/or candidate's family, regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure(s) and prosthetic devices.

Where it's running

  • University of Iowa Healthcare
    Iowa City, Iowa, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.